Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2024
Historique:
medline: 2 7 2024
pubmed: 2 7 2024
entrez: 2 7 2024
Statut: epublish

Résumé

The provision of tuberculosis preventive treatment is one of the critical interventions to reduce tuberculosis incidence and ultimately eliminate the disease, yet we still miss appropriate tools for an impactful intervention and treatment coverage remains low. We used recent data, epidemiological estimates, and research findings to analyze the challenges of each step of the cascade of tuberculosis prevention that currently delay the strategy implementation. We addressed research gaps and implementation bottlenecks that withhold key actions in tuberculosis case finding, testing for tuberculosis infection, provision of preventive treatment with safer, shorter regimens and supporting people to complete their treatment. Empowering communities to generate demand for preventive therapy and other prevention services in a holistic manner and providing adequate financial support to sustain implementation are essential requirements. The adoption of an effective, universal monitoring and evaluation system is a prerequisite to provide general and granular insight, and to steer progress of the tuberculosis infection strategy at global and local level.

Identifiants

pubmed: 38954723
doi: 10.1371/journal.pgph.0003306
pii: PGPH-D-23-02471
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e0003306

Informations de copyright

Copyright: © 2024 Matteelli et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Alberto Matteelli (A)

Institute of Infectious and Tropical Diseases, WHO Collaborating Centre for Tuberculosis Prevention, University of Brescia, Brescia, Italy.

Gavin Churchyard (G)

The Aurum Institute, Parktown, South Africa, School of Public Health, University of Witwatersrand, Johannesburg, South Africa.

Daniela Cirillo (D)

IRCCS San Raffaele Scientific Institute, Milan, Italy.

Saskia den Boon (S)

Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.

Dennis Falzon (D)

Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.

Yohhei Hamada (Y)

Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
University College London, London, United Kingdom.

Rein M G J Houben (RMGJ)

TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Avinash Kanchar (A)

Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.

Afrânio Kritski (A)

Rede Brasileira de Pesquisa em Tuberculose, REDE TB, Rio de Janeiro, Brasil.
Programa Acadêmico de Tuberculose, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.

Blessina Kumar (B)

The Global Coalition of TB Advocates, India.

Cecily Miller (C)

Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.

Dick Menzies (D)

McGill International TB Centre, McGill University, Montreal, Quebec, Canada.

Tiziana Masini (T)

Independent consultant, Lucca, Italy.

Classifications MeSH